Cite
491P Neoadjuvant nivolumab in early stage colorectal cancer
MLA
N. Zanaletti, et al. “491P Neoadjuvant Nivolumab in Early Stage Colorectal Cancer.” Annals of Oncology, vol. 31, Sept. 2020, p. S449. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........7c1c0e618937f4b9974c0ef6928cf6f1&authtype=sso&custid=ns315887.
APA
N. Zanaletti, Carlo Vitagliano, P.A. Ascierto, Jérôme Galon, Paolo Delrio, Alfredo Budillon, E. Di Gennaro, A. Avallone, S. De Franciscis, A. De Stefano, I. Boquet, Secondo Lastoria, Susan Costantini, Fabiana Tatangelo, Diana Giannarelli, A. Cassata, Ugo Pace, Francesca Collina, Vincenza Granata, & Aurelie Catteau. (2020). 491P Neoadjuvant nivolumab in early stage colorectal cancer. Annals of Oncology, 31, S449.
Chicago
N. Zanaletti, Carlo Vitagliano, P.A. Ascierto, Jérôme Galon, Paolo Delrio, Alfredo Budillon, E. Di Gennaro, et al. 2020. “491P Neoadjuvant Nivolumab in Early Stage Colorectal Cancer.” Annals of Oncology 31 (September): S449. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........7c1c0e618937f4b9974c0ef6928cf6f1&authtype=sso&custid=ns315887.